This inventor holds 2 USPTO granted patents. Top assignees: The Penn State Research Foundation, Musc Foundation for Research Development. Active years: 2009-2010.
Company Filing History:


Years Active: 2009-2010
Title: Joseph W Dolan: Innovator in RNA-targeting Technologies
Introduction
Joseph W Dolan is a notable inventor based in Mount Pleasant, SC (US). He has made significant contributions to the field of biotechnology, particularly in the development of ribozymes for therapeutic applications. With a total of 2 patents, his work focuses on innovative methods to target RNA in a tissue-specific and pathogen-specific manner.
Latest Patents
Dolan's latest patents include groundbreaking inventions related to tissue-specific and target RNA-specific ribozymes. The first patent discusses multi-ribozymes and their application in targeting RNA for the treatment of various diseases, including cancers and infections caused by bacteria, parasites, and viruses. This invention emphasizes the use of virions and viral vectors to deliver DNA encoding these multi-ribozymes effectively. The second patent focuses on the discovery and characterization of toxic agents that can target pathogens, aiming to treat and eradicate infections. This invention has significant implications for addressing drug-resistant bacteria and cancer cells.
Career Highlights
Throughout his career, Joseph W Dolan has worked with esteemed organizations such as the Penn State Research Foundation and the Medical University of South Carolina Foundation for Research Development. His innovative research has positioned him as a key figure in the biotechnology sector, contributing to advancements in medical treatments.
Collaborations
Dolan has collaborated with notable professionals in his field, including James S Norris and Gary A Clawson. These partnerships have further enhanced the impact of his research and inventions.
Conclusion
Joseph W Dolan's contributions to RNA-targeting technologies demonstrate his commitment to advancing medical science. His innovative patents and collaborations highlight the potential for significant breakthroughs in treating diseases and infections.